| Nov 18 |
What Makes NeuroPace (NPCE) a New Buy Stock
|
| Nov 18 |
Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 54.34%: Here's is How to Trade
|
| Nov 14 |
NeuroPace Third Quarter 2024 Earnings: Beats Expectations
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Nov 9 |
private equity firms who own 45% along with institutions invested in NeuroPace, Inc. (NASDAQ:NPCE) saw increase in their holdings value last week
|
| Nov 4 |
NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy
|
| Oct 16 |
NeuroPace Continues to Strengthen Management Team
|
| Sep 4 |
NeuroPace Strengthens Management Team with Two Key Appointments
|
| Aug 27 |
NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences
|
| Aug 16 |
Earnings Release: Here's Why Analysts Cut Their NeuroPace, Inc. (NASDAQ:NPCE) Price Target To US$14.57
|
